(Q47163824)

10 January 2018

title

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). (English)

1 reference

10 January 2018

0 references

3

1 reference

10 January 2018

Clive Ballard

6

1 reference

10 January 2018

Patrick Phillips

23

1 reference

10 January 2018

Tom Dening

Tom Dening

12

0 references

Robert Howard

Robert Howard

25

0 references

Richard G Brown

Richard G Brown

10

0 references

Martin Knapp

1

Martin Knapp

1 reference

10 January 2018

Clive Holmes

14

0 references

Sube Banerjee

Sube Banerjee

7

0 references

Ian G. McKeith

Ian McKeith

20

0 references

John T. O'Brien

John T O'Brien

22

0 references

Cornelius Katona

17

Cornelius Katona

1 reference

10 January 2018

Peter Bentham

9

Peter Bentham

1 reference

10 January 2018

Ajay Macharouthu

19

Ajay Macharouthu

1 reference

10 January 2018

Bart Sheehan

24

Bart Sheehan

1 reference

10 January 2018

Derek King

2

1 reference

10 January 2018

Jessica Adams

4

1 reference

10 January 2018

Ashley Baldwin

5

1 reference

10 January 2018

Robert Barber

8

1 reference

10 January 2018

Alistair Burns

11

1 reference

10 January 2018

David Findlay

13

1 reference

10 January 2018

Tony Johnson

15

1 reference

10 January 2018

Robert Jones

16

1 reference

10 January 2018

James Lindesay

18

1 reference

10 January 2018

Rupert McShane

21

1 reference

10 January 2018

language of work or name

English

0 references

publication date

13 October 2016

1 reference

10 January 2018

International Journal of Geriatric Psychiatry

published in

1 reference

10 January 2018

volume

32

1 reference

10 January 2018

issue

12

1 reference

10 January 2018

page(s)

1205-1216

1 reference

10 January 2018

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Maintenance cognitive stimulation therapy: an economic evaluation within a randomized controlled trial.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Dementia care costs and outcomes: a systematic review

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Determining the minimum clinically important differences for outcomes in the DOMINO trial.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Cognitive impairment in older people: future demand for long-term care services and the associated costs

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

23 May 2018

Memantine for dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

EuroQol--a new facility for the measurement of health-related quality of life

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Development of a new measure of health-related quality of life for people with dementia: DEMQOL.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

A guide to the standardized Mini-Mental State Examination.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

The validity of two versions of the GHQ in the WHO study of mental illness in general health care.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

Costs, effects and C/E-ratios alongside a clinical trial.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5724694

15 August 2018

Identifiers

DOI

10.1002/GPS.4583

1 reference

10 January 2018

PMCID

5724694

1 reference

10 January 2018

PubMed ID

27739182

1 reference

10 January 2018